| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $142,671 | 4 | 57 |
Sells | $82,072 | 3 | 43 |
| SHAMIR NACHUM | director | 1 | $83,996 | 0 | $0 | $83,996 |
| Fox David Morton | director | 1 | $49,901 | 0 | $0 | $49,901 |
| Rubinstein Samuel | director | 2 | $8,775 | 1 | $6,678 | $2,097 |
| Hess Shmuel | COO & Chief Commercial Officer | 0 | $0 | 2 | $75,394 | $-75,394 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other …
Over the last 12 months, insiders at MediWound Ltd. have bought $142,671 and sold $82,072 worth of MediWound Ltd. stock.
On average, over the past 5 years, insiders at MediWound Ltd. have bought $142,671 and sold $82,072 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SHAMIR NACHUM (director) — $83,996. Fox David Morton (director) — $49,901. Rubinstein Samuel (director) — $8,775.
The last purchase of 525 shares for transaction amount of $6,626 was made by Rubinstein Samuel (director) on 2026‑09‑01.
| 2026-09-01 | Sale | Rubinstein Samuel | director | 525 0.0041% | $12.72 | $6,678 | +5.43% | |
| 2026-09-01 | Rubinstein Samuel | director | 525 0.0041% | $12.62 | $6,626 | +5.43% | ||
| 2026-08-27 | Sale | Hess Shmuel | COO & Chief Commercial Officer | 3,958 0.0301% | $12.92 | $51,149 | +0.38% | |
| 2026-08-26 | Sale | Hess Shmuel | COO & Chief Commercial Officer | 1,865 0.0149% | $13.00 | $24,245 | +4.45% | |
| 2026-06-03 | SHAMIR NACHUM | director | 6,000 0.0563% | $14.00 | $83,996 | +0.76% | ||
| 2026-06-01 | Fox David Morton | director | 3,537 0.0332% | $14.11 | $49,901 | +0.07% | ||
| 2026-05-29 | Rubinstein Samuel | director | 150 0.0014% | $14.33 | $2,150 | -3.49% |
| Increased Positions | 49 | +73.13% | 936,135 | +16.26% |
| Decreased Positions | 26 | -38.81% | 460,692 | -8% |
| New Positions | 17 | New | 519,596 | New |
| Sold Out Positions | 10 | Sold Out | 154,236 | Sold Out |
| Total Postitions | 90 | +34.33% | 6M | +8.26% |